In three studies that evaluated GPBB in patients with leukemias and lymphomas, Horacek et al. found approximately 17–21.7% of patients with elevated GPBB concentrations after either AC-based chemotherapy or a preparative regimen for hematopoietic stem cell transplantation (114–116). This evidence concerns the gene PYGB and leukemia.